TH3.8 Retrospective study on the use of colonic stents in malignancy; a bridge to surgery or the end of the line?

Abstract Aim Colonic stenting is a management option for obstructed left sided colorectal malignancy in the emergency and elective setting. Stenting can provide bridge to curative surgery or adjuvant treatment. The aim of this study was assess role colonic cancer. Methods This retrospective cohort analyses prospectively collected data from two centres within one Health Board Wales. Patients were recorded cancer database, who underwent between January 2008 December 2021. Patient demographics, treatment pathways, length admission, stoma formation rates morbidity recorded. Results In total, 98 patients, with mean age 73.5 years (range 37–97) stent. majority 55% (n=54). sigmoid colon commonest site tumour 33 metastatic disease 82% (n=80). found 86% (n=84) patients successfully stented. admission 13 days. complication rate 23% (n=23), most commonly stent obstruction (n=6). 3 47% (n=46) received Five-year survival 19.3% (n=19). overall 10.2% (10 patients). Conclusion shows viable alternative surgical advanced obstructing but not as surgery. returned home following stenting, had low 19% at 5 years.